✨ Free AI Report
DaVita Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research DaVita Inc.
Company Research

DaVita Inc.: Business Overview, Financials & Competitive Analysis

DaVita Inc. scores 8/10 on the AskCyborg Cyborg Score (Strong). DaVita is a dialysis market leader positioned for sustainable growth through GLP-1 adoption benefits, demographic tailwinds, and strategic home-care expansion. In February 2026, DVA reached new all-time highs as the market digested projections for 2026 adjusted EPS of $13.60 to $15.00, well above the $12.65 analyst consensus. Clinical data released.

What is DaVita Inc.'s industry? DaVita Inc. (davita.com) operates in Healthcare Providers & Services - Dialysis and Kidney Care. AskCyborg classifies DaVita Inc. under Healthcare Providers & Services - Dialysis and Kidney Care in its company registry.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States, operating kidney dialysis centers and providing related lab services in outpatient dialysis center...

8/ 10Strong

Cyborg Score thesis

DaVita is a dialysis market leader positioned for sustainable growth through GLP-1 adoption benefits, demographic tailwinds, and...

Read the full analyst-debate transcript →
Industry Healthcare Providers & Services - Dialysis and Kidney Care
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest DaVita Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for DaVita Inc.

AskCyborg analysts argue the bull and bear cases for DaVita Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
DaVita Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

DaVita Inc. Overview

Pro stress-test →

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States, operating kidney dialysis centers and providing related lab services in outpatient dialysis centers, as well as outpatient, hospital inpatient, and home-based hemodialysis services. The company has evolved from a volume-based dialysis operator into a sophisticated, value-based manager of integrated kidney care.

Strategic Profile

Pro stress-test →

As of early February 2026, the company is being hailed as one of the top-performing large-cap stocks of the year. With a clarified regulatory horizon and massive share buybacks boosting earnings per share (EPS), DaVita has proven that the death of dialysis was greatly exaggerated. DaVita has embraced a collaboration with Elara Caring, paving ways into the kidney-specific, home-based care landscape and bolstering their intent to remain at the forefront of patient-specific healthcare solutions.

Competitive Landscape

Pro stress-test →

With a market capitalization of $7.85 billion, DaVita operates within the healthcare sector, specifically in the healthcare providers & services industry. DaVita dominates the U.S. dialysis market with a network of kidney dialysis centers, competing against smaller regional dialysis providers and integrated healthcare systems. The company's competitive advantages include scale, integrated care capabilities, clinical expertise, and established relationships with nephrologists and payers.

Industry Context

DaVita Inc. operates in Healthcare Providers & Services - Dialysis and Kidney Care.

Key facts

Founded: 1994 · Headquarters: Denver, Colorado · Revenue: $13.65B · Market cap: $7.85B

What the analysts stress-tested

The top findings that survived the multi-agent debate for DaVita Inc..

  • In February 2026, DVA reached new all-time highs as the market digested a massive upward revision in its 2026 earnings guidance
  • In 2025, the company repurchased roughly 15% of its outstanding shares, a move that has historically supercharged its EPS growth even when organic revenue growth is modest
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Strong Q4 2025 earnings beat and all-time high stock price following upward 2026 EPS guidance
  • February 2026Stock trading up 21.52% following Q4 earnings triumph and strategic initiatives
  • +2 moreTrack every material event for DaVita Inc. as it happens. Explore monitoring →
Get alerted when DaVita Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Fresenius Medical CareGlobal dialysis and kidney care provider→Renal Advantage Inc.Dialysis provider and integrated kidney care→Dialysis Corporation of AmericaRegional dialysis services→

Compare DaVita Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

DaVita Inc. operates in Healthcare Providers & Services - Dialysis and Kidney Care. See how the rest of the sector scores on the Cyborg framework.

Browse Healthcare Providers & Services - Dialysis and Kidney Care research →
NEW · MCP server

Ask your AI assistant about DaVita Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare DaVita Inc. and its top competitor on Cyborg Score”
“What did DaVita Inc. do this quarter?”
“Is DaVita Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does DaVita Inc. do?+
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States, operating kidney dialysis centers and providing related lab services in outpatient dialysis center...
What is DaVita Inc.'s Cyborg Score?+
DaVita Inc. has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are DaVita Inc.'s main competitors?+
Named competitors include Fresenius Medical Care, Renal Advantage Inc., Dialysis Corporation of America. The full competitive landscape is in the AskCyborg report.
How can I get the full DaVita Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the DaVita Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track DaVita Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.